Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
How to Develop and Implement a National Drug Policy (Second Edition)
(2001; 96 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentContributors
View the documentAbbreviations and acronyms
View the documentPreface
Open this folder and view contentsPart I: How to develop and implement a national drug policy
Open this folder and view contentsPart II: Key components of a national drug policy
View the documentReferences
View the documentSelected WHO publications and documents of related interest
View the documentBack cover
 

Abbreviations and acronyms

AIDS

Acquired immunodeficiency syndrome

ASEAN

Association of South-East Asian Nations

DRA

Drug regulatory authority

EDM

Department of Essential Drugs and Medicines Policy

EU

European Union

GMP

Good manufacturing practices

HIV

Human immunodeficiency virus

INN

International nonproprietary names

INRUD

International Network for Rational Use of Drugs

MoH

Ministry of Health

MSF

Médecins Sans Frontières

MSH

Management Sciences for Health

NDP

National drug policy

NGO

Nongovernmental organization

OAU

Organization of African Unity

OTC

Over-the-counter (drug)

TRIPS

(Agreement on) Trade-Related Aspects of Intellectual Property Rights

TFHE

Task Force on Health Economics

UNAIDS

Joint United Nations Programme on HIV/AIDS

UNICEF

United Nations Children’s Fund

UNFPA

United Nations Population Fund

WHA

World Health Assembly

WHO

World Health Organization

WTO

World Trade Organization

 

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: March 20, 2014